Rx Slowdown? Outlook?

I work at a top Rx shop, and things have been pretty slow. My hours have been as low as 20 hours of actual work and maybe as high as 60-70 hours so far this year. I have probably worked 40-50 hours on average the last couple months. It's been really nice after grinding through 2020

I know others in my group are still working 80+ hours, and we have had some pitch work, so I understand that this might not be the case for some people

想看看(1)其他人的表现以及(2)人们对RX的剩余时间是什么想法

注释 (33)

  • 副2Consulting
2021年4月18日- 2:23pm

RXconsultant here. Pretty much mostly been pitching. A few Rx jobs but not enough to keep everyone busy.

Everyone loaded up on covid 19 covent holidays, amend and extends, gov support bux etc. Bit ridiculous really. Treating this year as a wash as well and hoping for busy 2022!

2021年4月18日-5:25 pm

Not to sound too alarmist, butRXjust isn't really in a great spot right now. You've probably run the screens and have seen that there just aren't a lot of companies with catalysts in the next year and a half. Almost everyone is sitting on a ton of cash and has been able to refi out their capital structures to deal with their near-term maturities. As a result, there just isn't a lot to do at the moment, and that seems unlikely to change for a while.

  • 分析师2IB-M&A
2021年4月18日至下午6:44

是的,一个非常相似的观点EBs. Been very slow and not much on the horizon except for some one-offs

最有帮助的
  • 分析师2IB- Restr
2021年4月18日- 6:52pm

Same here. Been doing more debt advisory / bespoke financing work to fill the void but capital availability has definitely pushed out regular way restructuring transactions. We were working on an A&E + new money sponsor investment and the bank group eventually came to terms without outside capital.

去年+是一个疯狂的时代restructuring. Have seen historic peaks in filings and distress and then now unparalleled capital availability. Honestly a welcome change for a 2nd year analyst but to the 1st years and incomings who may be antsy: don't stress, there is 100% more cycles to come and likely a super cycle in the near future. All of the rescue capital that came in to bail out companies post covid haven't fixed the problem, just kicked the can out longer. Embrace the unconventional liability management work that you'll see until then bc that's equally constructive to your experience / future career inPE或者banking.

  • VPIB- Restr
Apr 19, 2021 - 11:57am

Did you mean to say we haven't seen a historic peak in filings? Last year was an extreme outlier, as bankruptcy filings have actually been trending significantly lower last year and this year relative to the last couple decades.

That being said, this is all about to change sooner than most think. The next 3-5 years will be extremely busy in the Rx space.

  • 展望IB-M&A
Apr 19, 2021 - 4:11pm

Why would you say its about to change over the next 3 - 5 years? Is it because companies just pushed their problems down the road 2 - 4 years? Or is there a more specific catalyst you're looking at

  • 分析师2IB-M&A
Apr 20, 2021 - 10:35am

Ah yes, me, when I was gullible sophomore in college a few years back: you know interest rates are low, cheap capital has flowed in, but I think there are a lot of catalysts on the horizon for a market correction leading to more restructuring. The associate interviewing me: you know, I said the same thing x years ago when I was coming out of school...

  • VPIB- Restr
2021年4月21日至11:32 AM

@plskystk-这是一个非常无知的陈述。首先,遇险空间每年都有很多活动(只是在这种利基习惯中有利的极端经济衰退期间的工作幅度)。我认为您可能还需要教育自己就陷入困境的债务投资进行教育(猜猜您专注于投资于稳定的健康公司,在您首次审查机会时会产生正现金流)。取决于基金的投资策略,这是一个非常有利可图的舞台,有许多机会可以瞄准。

2021年4月20日 - 上午11:03

诚实的问题责任管理与PE有何关系?我在一个偶尔这样做的团队中工作,但似乎并没有真正提高您的投资者 /并购技能。

2021年4月18日- 7:12pm

long term view is that it won't be amazing-Rx spiked due to covid and now that we're almost over the hump, turnarounds are still out there, just far fewer

大批

  • 分析师1IB- Cov
2021年4月18日- 9:22pm

Worst time to be inRXright now by far. At a good Rx group (HL/Gugg/Mill) and been doing nothing

  • 分析师2IB- Restr
Apr 19, 2021 - 11:07am

OP here. Hoping to turn this into a more meaningful discussion so bear with me.

Fed-backed资产购买,增加访问capital markets, etc. are keeping bond prices afloat, and investors are turning to riskier assets / yield. A Reorg survey from earlier in the year highlighted a relative shift in pricing - 90's becoming the new 80's for bonds. There's a lot of noise to look through. I think as we approach a near level of pre-Covid recovery, those businesses that have weaker business fundamentals (whether that be from Covid-driven acceleration / adoption or the business was underperforming prior to the pandemic - physical retail, legacy technology and media, etc.) will begin to show signs of underperformance relative to its peers and to economic recovery. There could be a normalization of bond prices or price discovery from the realization of underlying business deterioration and/or a shift in investor appetite and risk aversion. I think it'll be interesting to see how many Rx's will resurface from those that have already reorganized but cannot meet performance hurdles, newly negotiated debt indentures and credit agreements, etc.

Many believe there will be an uptick in activity in 2H21. What do people think about the above rationale? What do people think will be likely catalysts for an uptick in activity (Covid, rolloff of government aid to households and businesses, unexpected rise in inflation, etc.)? What are some industries that are still very much vulnerable and why?

  • 分析师1IB- Restr
Apr 19, 2021 - 11:17am

I'd tend to agree with that. Issue with the COVID downturn is that it wasn't caused by the business cycle, it was purely event driven by lockdowns. So all the companies/industries that were already over-levered and struggling were just able to get help from the government are still in deep trouble whenever (if) the Fed starts to raise rates or general interest rates start to go up again.

As for specific industries, I think the oil/gas companies will remain in a tough spot.

Apr 19, 2021 - 3:33pm

Will second everyone here and say that things have slowed since January of this year. Most of us are working on legacy deals expected to close sometime this year. Only a couple new毫米level bankruptcies and distress situations. That being said I think we're all expecting things to ramp up by Labor Day. I for one am happy I get to enjoy the impending spring and summer

  • 分析师2IB-M&A
Apr 20, 2021 - 10:09am

Yeah but the legacy deals are still churning out 120 hour weeks on a regular basis for some of us, really think OP is painting too broad of a stroke

Apr 20, 2021 - 10:10am

Vel suscipit repudiandae facere mollitia perferendis sit eligendi. Voluptas qui quo enim. Mollitia ut optio aut.

Enim quis facere mollitia et. Et rerum doloremque doloribus iste officiis quo excepturi et. Repudiandae delectus eligendi nesciunt et. Nam ut autem labore dignissimos voluptatum aliquam.

Rerum dignissimos non suscipit voluptatem earum sed. Similique consequatur totam vel repellat aliquam consequatur. Quas sunt cupiditate earum iure. Nam voluptatem architecto reprehenderit aliquid nisi inventore.

  • 实习生IB- gen
Apr 21, 2021 - 1:13pm

Ut nostrum ab qui aut blanditiis praesentium pariatium paruptate。Perferendis ea Maiores手工鼻子官方广告。Qui Laboriosam在Voluptas prechenderit Odio。亚利酯VEL CULPA LAUDANTIUM SINT OMNIS VOLUPTATEM。Vero nostrum aperiam et quibusdam。

Amet fugiat dicta voluptatibus perferendis illum accusantium nulla. Quibusdam earum dolor ullam possimus occaecati.

Et dolorum assumenda之选萃。Ut nesciunt dolores rem illo inventore amet nostrum eveniet. Illum nihil ducimus non ut dolor. Et aliquid iure ut labore. Numquam facere provident ipsam est. Quidem explicabo rerum aut aut.

Quam Sed Beatae Est Omnis Sint Laboriosam。Nam Asperiores减去了Facilis。Aut repellendus fugiat Labiosam occaecati fugit Eum。sit voultates quasi ut deleniti perferendis dicta。

开始讨论

流行内容See all

ECM, the high finance brain drain
+156 IB byIB -COV中的分析师1
副总裁禁止我去wfh
+110 IB byIB -COV中的分析师1
When GPA Matters
+93 IB byIB -COV中的分析师1
Associates who “Do” vs. “Review”
+81 IB byIB -COV中的分析师1
和一个孩子的分析师
+71 IB byIB -COV中的分析师1
“运动店”时间
+69 IB byIB -COV中的分析师1
美国银行vs摩根士丹利
+68 IB byIB的夏季助理-COV
FIG IB to Crypto VC?
+54 IB byIB -COV中的分析师1

Total Avg Compensation

December 2021万博app网页版

  • Director/MD (10) $853
  • Vice President (40) $360
  • Associates (246) $236
  • 2nd Year Analyst (148) $156
  • 3rd+ Year Analyst (34) $154
  • 实习/夏季助理(109) $146
  • 1st Year Analyst (529) $138
  • 实习/夏季分析师(402) $84

LeaderboardSee all